'The early stage trial finds that the vaccine is safe, causes few side effects, and induces strong immune responses in both parts of the immune system.'
As trials continue, there are more than 10,000 people in the UK who will participate in the next round, as well as a large trial involving 30,000 people in the U.S., 2,000 in South Africa, and 5,000 in Brazil.
According to the BBC, this vaccine, if proven to be effective in larger trials, may be available by the end of this year but won’t be widely available until later in 2021. Healthcare workers and others deemed essential workers will be first in line to receive the vaccine, as well as those at high-risk like the elderly and those who are have compromised.
Promising news out of UK on treatment and vaccine research. Lancet says Oxford vaccine candidate: “The early stage trial finds that the vaccine is safe, causes few side effects, and induces strong immune responses in both parts of the immune system”In the U.S., there are currently 3.9 million cases reported and 143,000 deaths from the virus. Globally, over a 24-hour period, nearly 260,000 new coronavirus cases — a new record — was reported on Saturday and 7,360 new fatalities were reported.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Oxford coronavirus vaccine induces strong immune response, early trial results suggestThe vaccine was found to produce both antibodies and virus-killing T cells.
Weiterlesen »
Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trialA potential coronavirus vaccine developed by Oxford University in the U.K. has produced an immune response in an early-stage human trial, according to newly released data published Monday in medical journal The Lancet.
Weiterlesen »
Promising Sign As Coronavirus Vaccine Developed By AstraZeneca And Oxford University Appears Safe, Early Trials ShowThe vaccine is still in early-stage clinical trials, and it is yet to be seen whether it can protect people against the virus.
Weiterlesen »
First human trial of Oxford coronavirus vaccine shows promiseAn experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
Weiterlesen »
Trial Shows ‘Robust Immune Response’ From Oxford Coronavirus VaccineA COVID-19 vaccine developed by the University of Oxford and the pharmaceutical firm AstraZeneca provoked “robust immune responses” in trial participants, the company said Monday
Weiterlesen »
Latest Results From Oxford Trial Raise Hopes for a Coronavirus VaccineMedical researchers at Oxford University announced on Monday that they had made significant progress in the search for a coronavirus vaccine, raising hopes that a preventative measure might be in reach. But predictions that a vaccine might be ready by the fall may be overly optimistic.
Weiterlesen »